A Study Evaluating BFB759 in Atopic Dermatitis
Key facts
- Where
- Bialystok, Bydgoszcz, Chorzów, Cracow, Gdansk, Malbork, Ostrowiec Świętokrzyski, Poznan, Pruszkow, Sosnowiec, Torun, Warsaw, Warszawa és Wroclaw, LengyelországSee the 18 sites
- Phase
- 2. fázis
Where in Lengyelország
- Clinicmed Daniluk Nowak Sp. k.Bialystok, LengyelországNo longer taking part
- Renew Clinic Sp. z o.o.Bialystok, LengyelországNo longer taking part
- Centrum Medyczne Kermed Renata Bijata-Bronisz I Ewa Kowalinska Sp. j.Bydgoszcz, LengyelországNo longer taking part
- DERMAPOLIS Medical Dermatology Center dr n. med. Edyta GębskaChorzów, LengyelországNo longer taking part
- Jagiellonskie Centrum Innowacji Sp. z o.o.Cracow, LengyelországNo longer taking part
- Penta Hospitals Badania Kliniczne sp. z o.o.Gdansk, LengyelországNo longer taking part
- Synexus Polska Sp z o.o.Gdansk, LengyelországNo longer taking part
- Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Sp. z o. oMalbork, LengyelországNo longer taking part
- Dermedic Jacek ZdybskiOstrowiec Świętokrzyski, LengyelországNo longer taking part
- EMC Instytut Medyczny S.A.Poznan, LengyelországNo longer taking part
- Twoja Przychodnia Poznanskie Centrum Medyczne Sp. z o.o.Poznan, LengyelországNo longer taking part
- Mcbk s.c. Iwona Czajkowska Anna Podrazka SzczepaniakPruszkow, LengyelországNo longer taking part
- Centrum Zdrowia Dziecka i Rodziny im Jana Pawla II w Sosnowcu Sp z o oSosnowiec, LengyelországNo longer taking part
- Medicover Integrated Clinical Services Sp. z o.o.Torun, LengyelországNo longer taking part
- Manufaktura Urody Sp. z o.o.Warsaw, LengyelországNo longer taking part
- Therapia Nova Sp z o.oWarsaw, LengyelországNo longer taking part
- Prywatna Praktyka Lekarska Ewa RingWarszawa, LengyelországNo longer taking part
- Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we WroclawiuWroclaw, LengyelországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Bluefin Biomedicine Inc.
- Trial code
- EU 2025-521624-30-00
- Record updated
- 2026. szeptember 28.
- Original description
To evaluate the efficacy of BFB759 in adult male and female participants with AD as assessed by Eczema Area and Severity Index (EASI) scoreRead full original descriptionShow less
A Phase 2, Parallel-arm, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Atopic Dermatitis (COMPASS 2-AD)
To evaluate the efficacy of BFB759 in adult male and female participants with AD as assessed by Eczema Area and Severity Index (EASI) score
Inclusion: Are adults (18 to 75 years) with a diagnosis of atopic dermatitis for at least one year; Have moderate to severe disease not well controlled by topical treatments; Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study.
Exclusion: Recently used medications that could interfere with the study; Have certain infections or other immune conditions; Are pregnant or breastfeeding.